Study to Assess the Moniotoring of Thyroid Function Test and Liver Function Test Prior to and After Prescribing Oral Amiodarone Therapy

Amiodarone is a class III antiarrhythmic agent however, its extensive side effect profile requires careful selection of patients and frequent monitoring. It may cause significant variations in thyroid function TFT and liver function tests LFT . The purpose of the study is to evaluate the performance of baseline liver function test and thyroid function test prior to and after initiating oral Amiodarone therapy. We had done a retrospective descriptive medical record review study initially and a Focus PDCA later to evaluate the quality improvement measures that had been undertaken as the reference of previous study recommendations. The repeated study reveals that there is a significant rise in baseline monitoring and follow up of liver function and thyroid function tests for patients treated with oral amiodarone therapy after implementing the monitoring protocol and clinical pharmacist intervention. Renukadevi. D | Dr. Harikrishnan | Dr. Becky Maria Biju "Study to Assess the Moniotoring of Thyroid Function Test and Liver Function Test Prior to and After Prescribing Oral Amiodarone Therapy" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-8 | Issue-4 , August 2024, URL: https://www.ijtsrd.com/papers/ijtsrd67191.pdf Paper Url: https://www.ijtsrd.com/management/other/67191/study-to-assess-the-moniotoring-of-thyroid-function-test-and-liver-function-test-prior-to-and-after-prescribing-oral-amiodarone-therapy/renukadevi-d